Research and experimental development on natural sciences and engineering
ARCTIC PHARMA AS
Revenue 2025
NOK 1.0m
Operating profit
NOK 135,000
Equity
NOK 2.0m
Incorporated
2012
Share capital
NOK 1.1m
Roles
Regnskapsfører
Styrets lederEirik Næss-Ulseth
StyremedlemBjørn Steen Skålhegg
StyremedlemGunnar Hvammen
StyremedlemAnne-Lise Børresen-Dale
StyremedlemKen Roger Rosendal
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| SKILLING SYSTEMER AS | 36.8% | 40189.000000 | 2025 |
| SOLAN CAPITAL AS | 19.7% | 21558.000000 | 2025 |
| BJØRN STEEN SKÅLHEGG | 6.8% | 7399.000000 | 2025 |
| ESPEN MARCELIUS GJEMS | 6.5% | 7116.000000 | 2025 |
| ANNE-LISE BØRRESEN-DALE | 5.3% | 5750.000000 | 2025 |
| HALVOR WØIEN | 4.3% | 4730.000000 | 2025 |
| KEN ROGER ROSENDAL | 3.3% | 3591.000000 | 2025 |
| CEROLU AS | 3.0% | 3279.000000 | 2025 |
| DRUG DISCOVERY LABORATORY AS | 1.8% | 2000.000000 | 2025 |
| CHRISTIAN BRUUSGAARD | 1.4% | 1531.000000 | 2025 |
| TORE JAHNSEN | 1.2% | 1268.000000 | 2025 |
| FREDRIK DAHL-PAULSEN | 1.2% | 1267.000000 | 2025 |
| ACADIA HOLDING AS | 0.9% | 1019.000000 | 2025 |
| ANJA RUPPELT OLDENBURG | 0.8% | 864.000000 | 2025 |
| HANS JACOB LÅHNE | 0.8% | 837.000000 | 2025 |
| TUVA HOLT HERENG | 0.7% | 750.000000 | 2025 |
| ANDERS KORVALD | 0.6% | 705.000000 | 2025 |
| VADVIN AS | 0.6% | 700.000000 | 2025 |
| ANNE ULVESTAD | 0.6% | 660.000000 | 2025 |
| SIGURD ØRSTAVIK | 0.5% | 600.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.